Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort.
Watera, C; Nakiyingi, J; Miiro, G; Muwonge, R; WHITWORTH, JA G; Gilks, CF; FRENCH, N;
2004
AIDS (London, England), (2004).18 8 10.1097/00002030-200405210-00018.
Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.
Laine, C; Mwangi, T; Thompson, CM; Obiero, J; Lipsitch, M; SCOTT, JA G;
2004
Infection and immunity, (2004).72 6 10.1128/IAI.72.6.3331-3335.2004.
Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
Garmory, HS; Freeman, D; Brown, KA; Titball, RW;
2004
Vaccine, (2004).22 8 10.1016/j.vaccine.2003.09.020.
Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: survey of 73 general practices in Britain.
BREEZE, E; MANGTANI, P; FLETCHER, AE; Price, GM; KOVATS, S; Roberts, J;
2004
BMC family practice, (2004).5 1 10.1186/1471-2296-5-8.
Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné, S; Ramsay, M; Balogun, K; EDMUNDS, WJ; Mortimer, P;
2004
Journal of clinical virology, (2004).29 4 10.1016/j.jcv.2003.09.016.
The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.
Melegaro, A; EDMUNDS, WJ;
2004
European journal of epidemiology, (2004).19 4 10.1023/b:ejep.0000024701.94769.98.
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
POLLEY, SD; Mwangi, T; Kocken, CH M; Thomas, AW; Dutta, S; Lanar, DE; Remarque, E; Ross, A; Williams, TN; Mwambingu, G; Lowe, B; CONWAY, DJ; Marsh, K;
2004
Vaccine, (2004).23 5 10.1016/j.vaccine.2004.05.031.
The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales.
Melegaro, A; EDMUNDS, WJ;
2004
European journal of epidemiology, (2004).19 4 10.1023/b:ejep.0000024752.48929.bd.
Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon (Vol 98, pg 757, 2004).
Kimbi, HK; TETTEH, KK A; Polley, SD; CONWAY, DJ;
2004
Transactions of the Royal Society of Tropical Medicine and Hygiene, (2004).98 12 10.1016/j.trstmh.2004.03.006.
Vaccination for vivax malaria: targeting the invaders.
Polley, SD; McRobert, L; SUTHERLAND, CJ;
2004
Trends in parasitology, (2004).20 3 10.1016/j.pt.2003.12.003.